Petros Pharmaceuticals, Inc. (PTPI)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 12:23PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 4.52M |
| Enterprise Value | -132.62k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.25 |
| Price/Book (mrq) | 0.37 |
| Enterprise Value/Revenue | -0.02 |
| Enterprise Value/EBITDA | 0.03 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.24 |
| 52-Week Change 3 | -82.76% |
| S&P500 52-Week Change 3 | 23.57% |
| 52 Week High 3 | 5.2400 |
| 52 Week Low 3 | 0.6020 |
| 50-Day Moving Average 3 | 1.2085 |
| 200-Day Moving Average 3 | 1.7100 |
Share Statistics
| Avg Vol (3 month) 3 | 789.91k |
| Avg Vol (10 day) 3 | 212.73k |
| Shares Outstanding 5 | 6.88M |
| Implied Shares Outstanding 6 | 6.88M |
| Float 8 | 6.2M |
| % Held by Insiders 1 | 11.80% |
| % Held by Institutions 1 | 1.70% |
| Shares Short (Apr 15, 2024) 4 | 69.84k |
| Short Ratio (Apr 15, 2024) 4 | 0.08 |
| Short % of Float (Apr 15, 2024) 4 | 1.27% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 1.02% |
| Shares Short (prior month Mar 15, 2024) 4 | 88.39k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Dec 01, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -140.20% |
| Operating Margin (ttm) | 1,383.29% |
Management Effectiveness
| Return on Assets (ttm) | -20.32% |
| Return on Equity (ttm) | -55.95% |
Income Statement
| Revenue (ttm) | 5.82M |
| Revenue Per Share (ttm) | 2.68 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -7.48M |
| Net Income Avi to Common (ttm) | -13.81M |
| Diluted EPS (ttm) | -6.3500 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.34M |
| Total Cash Per Share (mrq) | 1.94 |
| Total Debt (mrq) | 8.28M |
| Total Debt/Equity (mrq) | 66.32% |
| Current Ratio (mrq) | 1.89 |
| Book Value Per Share (mrq) | 4.03 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7.63M |
| Levered Free Cash Flow (ttm) | -1.39M |
© 2024 Yahoo. All rights reserved.